Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Ennezat

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Circulation|November 1, 2000
Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failureS L Malendowicz, P V Ennezat, M Testa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 28, 1998
[Effects of high sodium intake on ventricular remodeling in mice]P V Ennezat, R Houel, F Heloire, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 23, 2008
[Heparin-induced thrombocytopenia: a case of persistent thrombocytopenia]M Jourdain, P-V Ennezat, J Darchis, et al.
Journal of Cardiac Failure|September 19, 2001
Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjectsF Latif, S Tandon, R Obeleniene, et al.
Journal of the American College of Cardiology|July 14, 2001
Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymesP V Ennezat, S L Malendowicz, M Testa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[Tako-tsubo syndrome and left ventricular obstruction: report of one case]P Marboeuf, P V Ennezat, X Gonin, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 5, 2007
[Pulmonary embolism and right diaphragmatic paralysis: "one train can hide another"]C Charbonnel, P V Ennezat, J Darchis, et al.
Journal of Cardiovascular Pharmacology|June 8, 2001
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteersM S Berlowitz, F Latif, S R Hankins, et al.
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance]D Logeart, A Gambert, P Beyne, et al.
Circulation|March 1, 2000
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failureU P Jorde, P V Ennezat, J Lisker, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Circulation|November 1, 2000
Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failureS L Malendowicz, P V Ennezat, M Testa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 28, 1998
[Effects of high sodium intake on ventricular remodeling in mice]P V Ennezat, R Houel, F Heloire, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 23, 2008
[Heparin-induced thrombocytopenia: a case of persistent thrombocytopenia]M Jourdain, P-V Ennezat, J Darchis, et al.
Journal of Cardiac Failure|September 19, 2001
Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjectsF Latif, S Tandon, R Obeleniene, et al.
Journal of the American College of Cardiology|July 14, 2001
Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymesP V Ennezat, S L Malendowicz, M Testa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[Tako-tsubo syndrome and left ventricular obstruction: report of one case]P Marboeuf, P V Ennezat, X Gonin, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 5, 2007
[Pulmonary embolism and right diaphragmatic paralysis: "one train can hide another"]C Charbonnel, P V Ennezat, J Darchis, et al.
Journal of Cardiovascular Pharmacology|June 8, 2001
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteersM S Berlowitz, F Latif, S R Hankins, et al.
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance]D Logeart, A Gambert, P Beyne, et al.
Circulation|March 1, 2000
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failureU P Jorde, P V Ennezat, J Lisker, et al.
Pageof 3